Hook Group

All the posts published.

NetScientific hails the potential of investee company’s cancer immunotherapy

Jun 16, 2021
-
ProActive
The latest data points to a 71% response rate to the drug

NetScientific business unit eyes opportunities to significantly boost top revenues

Jun 16, 2021
-
ProActive
Chairman John Clarkson said: “In what has been a challenging year for ProAxsis, positive management actions have helped transform the company’s outlook"

NetScientific PLC: WH Ireland sees significant potential upside

Jun 16, 2021
-
ProActive
The City broker pointed to the last fair value calculation for the assets held by the investment company, which specialises in life sciences and technology

NetScientific’s ProAxsis to validate and commercialise AstraZeneca’s Coronavirus vaccine assay

Jun 16, 2021
-
ProActive
It is envisaged that the validation and initial commercialisation can be achieved largely from ProAxsis' existing resources

NetScientific on the rise again after PDS cancer trial

Jun 16, 2021
-
ProActive
“The data provide early evidence of notable clinical activity, and we saw effective tumour regression in these patients"

NetScientific receives enthusiastic response to fundraising

Jun 16, 2021
-
ProActive
"This placement provides further impetus behind our model of 'capital-light' investment combined with pro-active management and value-added support to our portfolio," said Ilian Ilev, NetScientific's CEO

NetScientific follows its money as investee company announces plans to raise US$45mln

Jun 16, 2021
-
ProActive
NetScientific currently has a 5.7% stake in PDS Biotechnology, which is at the cutting edge of immuno-oncology

NetScientific: City broker provides thumbs up following PDS funding round

Jun 16, 2021
-
ProActive
WHI Ireland has a sum-of-the-parts valuation for the shares of 162p - a 40% premium to the current price

NetScientific participates in PDS Biotechnology $45m equity issue and related party transaction

Jun 16, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the "Group" or the "Company")   NetScientific participates in PDS Biotechnology $45m equity issue and related party transaction London, UK – 16 June 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company PDS Biotechnology Corporation ("PDS") (Nasdaq: PDSB) yesterday announced an [...]

PDS Biotech Announces Proposed Offering of Common Stock

Jun 15, 2021
-
News, PDS Biotechnology, RNS Announcements
NetScientific plc ("NetScientific", the "Group" or the "Company")   PDS Biotech Announces Proposed Offering of Common Stock   London, UK – 15 June 2021 - NetScientific plc (AIM: NSCI), the international life sciences and sustainability technology investment and commercialisation Group, announces that its portfolio company, PDS Biotechnology Corporation (Nasdaq: PDSB), has announced that it has commenced an [...]
Hook Group Archives - NetScientific